|
|
193381 |
nTALECD for_MSH1 exon21_1397NC |
For specific C-to-T base editing to introduce an amino acid mutation in the coding sequence of AtMSH1. (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
199797 |
E1_pENTR_L1-L4_HD_G1333-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
199798 |
E1_pENTR_L1-L4_NG_G1333-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
199799 |
E1_pENTR_L1-L4_NI_G1333-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
199800 |
E1_pENTR_L1-L4_NN_G1333-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
199801 |
E3_pENTR_L3-L2_HD_G1333-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
199802 |
E3_pENTR_L3-L2_NG_G1333-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
199803 |
E3_pENTR_L3-L2_NI_G1333-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
199804 |
E3_pENTR_L3-L2_NN_G1333-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191609 |
E3_pENTR_L3-L2_NI_G1333-DddA11-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191610 |
E3_pENTR_L3-L2_NN_G1333-DddA11-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191611 |
E3_pENTR_L3-L2_HD_G1397-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191612 |
E3_pENTR_L3-L2_NG_G1397-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191613 |
E3_pENTR_L3-L2_NI_G1397-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191614 |
E3_pENTR_L3-L2_NN_G1397-DddA11'-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191596 |
E3_pENTR_L3-L2_HD_G1397-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191597 |
E3_pENTR_L3-L2_NI_G1397-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191598 |
E3_pENTR_L3-L2_NN_G1397-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191599 |
E1_pENTR_L1-L4_HD_G1333-DddA11-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191600 |
E1_pENTR_L1-L4_NG_G1333-DddA11-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191601 |
E1_pENTR_L1-L4_NI_G1333-DddA11-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191602 |
E1_pENTR_L1-L4_NN_G1333-DddA11-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191603 |
E1_pENTR_L1-L4_HD_G1397-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11′), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191604 |
E1_pENTR_L1-L4_NG_G1397-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191605 |
E1_pENTR_L1-L4_NI_G1397-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191606 |
E1_pENTR_L1-L4_NN_G1397-DddA11'-C |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11'), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191607 |
E3_pENTR_L3-L2_HD_G1333-DddA11-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191608 |
E3_pENTR_L3-L2_NG_G1333-DddA11-N |
C- and N termini of platinum TALEN, a half of the evolved DddA (DddA11), and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191583 |
E1_pENTR_L1-L4_HD_G1397-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191584 |
E1_pENTR_L1-L4_NG_G1397-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191585 |
E1_pENTR_L1-L4_HD_G1397-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191586 |
E1_pENTR_L1-L4_NG_G1397-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191587 |
E3_pENTR_L3-L2_HD_G1333-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191588 |
E3_pENTR_L3-L2_NI_G1333-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191589 |
E3_pENTR_L3-L2_NN_G1333-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191590 |
E3_pENTR_L3-L2_HD_G1333-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191591 |
E3_pENTR_L3-L2_NI_G1333-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191592 |
E3_pENTR_L3-L2_NN_G1333-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191593 |
E3_pENTR_L3-L2_HD_G1397-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191594 |
E3_pENTR_L3-L2_NI_G1397-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191595 |
E3_pENTR_L3-L2_NN_G1397-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191579 |
E1_pENTR_L1-L4_HD_G1333-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191580 |
E1_pENTR_L1-L4_NG_G1333-DddtoxA-C |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191581 |
E1_pENTR_L1-L4_HD_G1333-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
191582 |
E1_pENTR_L1-L4_NG_G1333-DddtoxA-N |
C and N termini of platinum TALEN, 1/2 a cytidine deaminase domain of DddA of B. cenocepacia, and a uracil glycosylase inhibitor (Synthetic)
|
Arimura |
Feb 09, 2024 |
|
|
206959 |
pET21b-hHNF4aORF-1 |
HNF4a (Hepatocyte Nuclear Factor alpha4 Variant 2) (Homo sapiens)
|
Ross |
Feb 09, 2024 |
|
|
209133 |
pcDNA3.1_hCAR.Variant3 |
constitutive androstane receptor (CAR), Variant 3 (Homo sapiens)
|
Ross |
Feb 09, 2024 |
|
|
179486 |
KJ740(DE3) |
none (Other)
|
Hansen |
Feb 09, 2024 |
|
|
195022 |
pENTR-Creb5(HA) |
HA-tagged Creb5 (full length, 508aa) (Bos taurus)
|
Lassar |
Feb 09, 2024 |
|
|
195025 |
pENTR-Creb5(T59/T61A)(HA) |
HA-tagged Creb5 (full length, 508aa; with with T59/T61A mutation) (Bos taurus)
|
Lassar |
Feb 09, 2024 |
